Request an Appointment:
Online or Call 1-888-824-0200

Services Offered

Risk Reduction and Prevention

In the Upper Aerodigestive Cancer Risk Clinic, we offer programs and treatments to prevent or end behaviors and addictions that increase a person's risk for cancer. Treatments may include:

  • Combined use of counseling and medication to help smokers overcome tobacco addiction
  • Genetic counseling for family members through the University of Chicago Cancer Risk Clinic
  • Depression counseling and therapy
  • Discussions about future clinical trials for chemo-prevention drugs
  • Stress management
  • Skills to cope with cravings
  • Relapse prevention plan

Early Detection and Treatment

Dr. D. Kyle Hogarth holding fluorescence bronchoscopy equipment

Our doctors use advanced diagnostic methods, including fluorescence bronchoscopy--a technique that detects cancerous tissue before it spreads beyond the lung. This method enables treatment at an early stage, which increases the possibility of a positive result.

D. Kyle Hogarth, MD, co-director of the Upper Aerodigestive Cancer Risk Clinic, is exploring a new approach to fluorescence bronchoscopy and evaluating its use for the development of minimally invasive treatment procedures. Dr. Hogarth's research explores effective practices for using this technique in screening and prevention.

Advanced Imaging

Dr. Hogarth is also one of the first physicians in Illinois to work with the superDimension/Bronchus System, which uses 3-D imaging technology to detect lesions in lung tissue. This device operates like global positioning systems (GPS) in vehicles, providing pinpoint accuracy in non-surgical biopsy of tiny lesions deep within the lung. Before this system, doctors could only use surgical procedures and needle biopsies to test for cancer in lower lung tissue.

Doctors in the clinic also work closely with chest radiologists, who use computed tomography (CT) and computer-assisted detection methods to accurately measure and assess tumor growth. Our specialists use 3-D imaging and other enhanced techniques that offer greater precision in targeting cancerous tissue for treatment.

Leading-Edge Research

In the Francis Lederer Aerodigestive Cancer Research Program, our physicians study DNA, tissue and serum samples, and clinical outcomes. With this research, doctors are investigating the possible use of simpler, earlier methods of diagnosis.

Our research teams are investigating potential methods of testing family members for genetic markers that may indicate high risk. One of the clinic's goals is to eventually create "risk profiles" that can help physicians design prevention plans and individualized screening plans for at-risk patients and their families.

More Information